Harbor Investment Advisory’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23
Closed -$10K 1312
2021
Q2
$10K Sell
23
-232
-91% -$91.9K ﹤0.01% 1014
2021
Q1
$100K Sell
255
-136
-35% -$67K 0.02% 480
2020
Q4
$219K Sell
391
-169
-30% -$107K 0.04% 299
2020
Q3
$392K Buy
560
+460
+460% +$359K 0.08% 188
2020
Q2
$79K Buy
100
+8
+9% +$6.03K 0.02% 380
2020
Q1
$55K Buy
92
+38
+70% +$37K 0.01% 388
2019
Q4
$61K Buy
+54
New +$58.7K 0.01% 386

Other funds holding BLUE

Harbor Investment Advisory's BLUE Position: Q3 2021 in Review

Harbor Investment Advisory sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 23 shares — an estimated $10K sold.

Harbor Investment Advisory first reported a position in BLUE in Q4 2019 and held it in 7 quarters. The position peaked at $392K in Q3 2020. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

  • Harbor Investment Advisory reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
  • Harbor Investment Advisory sold 23 bluebird bio shares in Q3 2021, an estimated $10K.
  • Harbor Investment Advisory first reported a position in bluebird bio in Q4 2019 and held it in 7 quarters.
  • Harbor Investment Advisory's bluebird bio position peaked at $392K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Harbor Investment Advisory's 13F filing for Q3 2021, filed 12 Oct 2021.